biotech
HPV vaccine slashes rate of infection by 86% in UK
June 18, 2018Medical Communications, Sales and Marketing HPV, biotech, drugs, pharma, pharmaceutical, vaccination
Since the introduction of the vaccination against the Human Papilloma Virus in 2008, there has been an 86% drop in …
£20bn promised to NHS but questions over where money will come from
June 18, 2018Medical Communications, Sales and Marketing NHS, UK government, biotech, drugs, pharma, pharmaceutical
Theresa May finally attempted to tackle the elephant in the room for the UK government, well, the one other than …
Top Ten most popular articles on Pharmafile.com this week
June 15, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical
Another busy in week in pharma has seen a number of companies release promising data on their drugs, Roche’s study …
New Jersey attempts to lure Teva HQ with tax incentives
June 15, 2018Medical Communications Teva, biotech, drugs, pharma, pharmaceutical
Teva has been doing some major global restructuring since Kare Schultz came to the helm of the embattled, Israeli drugmaker. …
Gene therapy offers hope for those with paralysis
June 15, 2018Medical Communications, Research and Development biotech, drugs, pharma, pharmaceutical
Researchers at King’s College London (KCL) have made significant progress to being able to offer a treatment to those with …
Danger of Sanofi’s dengue vaccine confirmed in new study
June 14, 2018Medical Communications, Research and Development Sanofi, biotech, dengue, dengvaxia, drugs, pharma, pharmaceutical
A study that thoroughly analyses the impact of Sanofi’s dengue vaccine has confirmed what was feared – children without prior …
UK immigration rules to be waived to bring in more doctors
June 14, 2018Medical Communications NHS, biotech, drugs, pharma, pharmaceutical
The NHS’ recruitment crisis has been on-going for a number of years, with an ageing population and a higher workload …
Report highlights that half of women in science face harassment
June 14, 2018Medical Communications biotech, drugs, pharma, pharmaceutical
Arriving at a particularly low point for the reputation of the biotech, after STAT revealed that a party at BIO …
Vaccination rates in parts of US fall to dangerous levels
June 13, 2018Research and Development anti-vax, biotech, drugs, pharma, pharmaceutical, vaccination
The anti-vaxxer movement is the scourge of meticulously researched science and yet, in certain states in the US, it seems …
J&J continues to shed assets, with $2.1bn diabetes unit sale
June 13, 2018Research and Development, Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical
Just last week, Johnson & Johnson announced that it had received an offer from Fortive for its medical sterilisation unit, …
Investors stump up cash for anti-ageing start-up
June 12, 2018Research and Development, Sales and Marketing Juvenescence, biotech, drugs, pharma, pharmaceutical
Defeating the ageing process is a pie-in-the-sky idea that has resulted, so far, in a rich vein of parody rather …
Brexit negotiations: Is the public’s health a priority?
June 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, brexit, drugs, pharma, pharmaceutical
The Brexit decision has created a huge amount of question marks for many industries and each is vying with each …
Research casts doubts over CRISPR safety
June 12, 2018Manufacturing and Production, Research and Development biotech, crispr, drugs, pharma, pharmaceutical
Research emerging from two studies, published in same issue of Nature, has raised significant questions over just how safe CRISPR …
Another failure in Alzheimer’s creates bleak outlook for treatment
June 12, 2018Manufacturing and Production, Research and Development Alzheimer's, AstraZeneca, Eli Lilly, biotech, drugs, pharma, pharmaceutical
Finding a treatment for Alzheimer’s disease has been one of the aims of big pharma for last few decades, but …
Alexion goes back to roots with Complement deal
June 11, 2018Manufacturing and Production, Sales and Marketing Alexion, biotech, drugs, pharma, pharmaceutical, soliris
Alexion has made a lot of money from investing in the science behind complement inhibitors – C5 inhibitor, Soliris, has …
Latest content
